To determine the role of FAM83A in trastuzumab-resistance, FAM83A expression was examined in HER2+ BC cell lines using the Cell Line Encyclopedia database [42] and correlated with published data on trastuzumab sensitivity, where available [43–46] (Fig 2A). The gene discussed is ERBB2; the disease is breast cancer.